Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NBIS vs GSK✓SelectedUSD · GSKNBIS vs GSK performance historyLatest closeAs of-7.55%11/16
Stock and ETF performance explorer

NBIS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+435.6%
GSK return
+43.1%
Excess return
+392.6%
Maximum drawdown
-62.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-7.6%-0.1%-7.5%-7.6%
7D-24.3%-1.3%-23.0%-24.6%
30D-35.3%+2.7%-38.0%-34.2%
3M-61.4%+2.7%-64.1%-60.5%
6M-51.3%+3.3%-54.6%-49.9%
YTD+28.0%+6.5%+21.5%+34.0%
1Y+28.2%+10.7%+17.6%+35.6%
All+435.6%+43.1%+392.6%+714.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling